Omnicare Clinical Research Earns Highest Accreditation in Medidata Solutions CRO Program
FOR IMMEDIATE RELEASE
Omnicare Clinical Research Earns Highest Accreditation
in Medidata Solutions CRO Program
Global CRO Broadens EDC-Related Services for Sponsors
through Medidata ASPire to Win Program
NEW YORK, N.Y. – October 28, 2009 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that global contract research organization (CRO) Omnicare Clinical Research has attained Rave Accredited Plus, the most advanced level in Medidata’s ASPire to Win® program for CROs and other service providers. With this accreditation, Omnicare Clinical Research can now offer sponsors a comprehensive suite of Medidata Rave® services that will enable them to cost-effectively increase clinical research efficiencies across all therapeutic areas and trial phases.
As a leading Phase I through IV CRO with locations in 31 countries, Omnicare Clinical Research manages trials for pharmaceutical, biotechnological, nutraceutical and medical device companies of all sizes and specialties. The CRO first joined Medidata’s ASPire to Win program in January 2009 in order to field increasing demand for the Medidata Rave electronic clinical data capture (EDC), reporting and management solution.
Omnicare Clinical Research’s clinical data management force of more than 60 programming professionals supports more than 100 EDC database configurations each year. As a Rave Accredited Plus partner, Omnicare Clinical Research is now able to independently offer its customers end-user training, study build, reporting, outputs, integration and migration services for the Medidata Rave platform.
“From large, global pharmaceutical companies to specialty biotechs, our customers continue to view Medidata Rave as a critical component of the clinical development process and rely on the solution as a hub of clinical data,” said Michael Burton, Director of eClinical Solutions at Omnicare Clinical Research. “The ASPire to Win program has been instrumental in allowing us to easily and efficiently meet our customers’ needs for EDC at all phases of clinical trials.”
“Omnicare Clinical Research has consistently shared our eClinical vision of driving efficiencies and quality across the clinical development process through best-of-breed clinical trial technology,” said Graham Bunn, Vice President of Global Partnership at Medidata Solutions. “Omnicare’s ASPire to Win accreditation will further enable them to deliver the Medidata Rave tools and services that sponsors need to execute successful trials of all sizes, phases and therapeutic areas.”
Medidata first announced ASPire to Win in April 2005 as a partner program designed to enable select CROs and other service providers to offer Medidata Rave implementation services. Since then, ASPire to Win has grown to include more than 20 partners, ranging from smaller clinical consultancies to large, global CROs. For more information about the ASPire to Win program, visit www.mdsol.com/partnerships/cros.htm.
Medidata Solutions and Omnicare Clinical Research will each exhibit at the CDISC North America Interchange, taking place November 9–13 in Baltimore, Md., and can be visited at booths #10 and 19, respectively, to discuss their eClinical capabilities in further detail.
About Omnicare Clinical Research
Headquartered in King of Prussia, PA, Omnicare Clinical Research (www.omnicarecr.com), provides clinical development services to pharmaceutical, biotechnology, nutraceutical and medical device companies through its office locations in 31 countries worldwide. As a premier Phase I–IV contract research organization, Omnicare Clinical Research features diverse therapeutic expertise and a comprehensive scope of clinical service offerings. Additionally, the company is an industry leader in geriatrics-focused drug studies. Omnicare Clinical Research focuses on providing clients with a superior drug development experience through strong project management, exceptional service and proactive solutions. The company is a subsidiary of Omnicare, Inc. (NYSE: OCR), a leading provider of pharmacy services to long-term care facilities and other chronic care settings comprising approximately 1.4 million beds in 47 states, the District of Columbia and Canada.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer®), investigator benchmarking and budgeting (Medidata Grants Manager™), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor™), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.
Contact:
Susan McCarron
Lois Paul & Partners
781.782.5767
Susan_McCarron@lpp.com